# China NMPA Drug Inspection - Hebei Huarong Pharmaceutical Co., Ltd. - Gastrodia elata

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/hebei-huarong-pharmaceutical-co-ltd/116e0476-84fe-4ec2-8ca4-16d2ba9be500/
Source feed: China

> China NMPA drug inspection for Hebei Huarong Pharmaceutical Co., Ltd. published January 15, 2018. Drug: Gastrodia elata. The Tianjin Municipal Market and Quality Supervision and Management Commission issued an announcement on January 15, 201

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Tianjin Municipal Drug Quality Bulletin (Issue 4, 2017, Serial No. 31)
- Company Name: Hebei Huarong Pharmaceutical Co., Ltd.
- Publication Date: 2018-01-15
- Drug Name: Gastrodia elata
- Inspection Finding: [Characteristics]
- Action Taken: Market supervision law enforcement departments at all levels in the city have promptly investigated and dealt with the non-conforming drugs found in the supervision and sampling according to law.
- Summary: The Tianjin Municipal Market and Quality Supervision and Management Commission issued an announcement on January 15, 2018, summarizing its 2017 drug supervision and sampling inspections. These inspections, conducted under the "2017 Tianjin Municipal Drug Supervision and Sampling Inspection Implementation Plan," aimed to ensure drug quality and public safety across Tianjin's pharmaceutical supply chain.

The inspections identified nine batches of drugs from various manufacturers and medical institutions that failed to meet established quality standards. Key companies and institutions cited include Anhui Huilong Traditional Chinese Medicine Pieces Co., Ltd., Anguo Qiao Traditional Chinese Medicine Pieces Co., Ltd., Bozhou Boyaotang Pharmaceutical Co., Ltd., Tianjin Second Hospital, Tianjin Medical University General Hospital, and Hebei Shunquanlong Pharmaceutical Co., Ltd.

Violations encompassed a range of quality deficiencies. Issues included unqualified content determination for Cassia Seed, excessive total ash and acid-insoluble ash in Beehives, and moisture and total ash problems in Cistanche deserticola. Hospital-prepared medications exhibited issues such as incorrect identification of camphor in Compound Menthol Nasal Drops, unsatisfactory appearance in Ciprofloxacin Hydrochloride Lotion, and unacceptable microbial limits in Anti-leukoplakia Cream. Gastrodia elata also failed appearance standards.

These products were assessed against official regulatory frameworks, specifically the Chinese Pharmacopoeia (2010 and 2015 Editions) and the "Tianjin Medical Institution Preparation Standards" (2016 Edition). The announcement stated that municipal market supervision and law enforcement departments promptly investigated and dealt with the identified substandard drugs, ensuring compliance and safeguarding public health.

Company: https://www.globalkeysolutions.net/companies/hebei-huarong-pharmaceutical-co-ltd/3c5934a4-cb71-48c2-8c3d-477347cc7cf0/